These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2799898)

  • 1. Should autologous blood that tests positive for infectious diseases be used or discarded? A decision analysis approach.
    Dzik WH; Devarajan S
    Transfusion; 1989 Oct; 29(8):743-5. PubMed ID: 2799898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious disease marker testing of the autologous blood donor. A case study in clinical ethics.
    Domen RE
    Arch Pathol Lab Med; 1995 Sep; 119(9):807-10. PubMed ID: 7668938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?
    Perkins J; Kaminer L; Kruskall M; Cannon M; Uhl L; Dzik W; Silver H; O'Neill M; Popovsky M; King K; Ness P; AuBuchon J; Shapiro A; Yomtovian R; Petz LD
    Transfusion; 2000 Jun; 40(6):752-4. PubMed ID: 10865000
    [No Abstract]   [Full Text] [Related]  

  • 4. Infectious disease markers in autologous blood donors and first-time volunteer blood donors: 14 years' experience in a blood center.
    Hernández JM; Cid J; Claparols M; Mallafré E; Pla R
    Haematologica; 2004 Jul; 89(7):889-91. PubMed ID: 15257955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing infectious or untested autologous blood components: the ethical dilemma of private rights versus public safety.
    Sazama K
    Arch Pathol Lab Med; 2005 Oct; 129(10):1212-3. PubMed ID: 16196504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autologous transfusion: when best should not be the enemy of good enough...].
    de Montalembert M
    Transfus Clin Biol; 1999 Sep; 6(5):329-32. PubMed ID: 10528390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The need for thorough infection screening in donors of autologous blood].
    Heim MU; Mempel W
    Beitr Infusionsther; 1991; 28():313-6. PubMed ID: 1725645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
    O'Hara JF; Sprung J; Klein EA; Dilger JA; Domen RE; Piedmonte MR
    Urology; 1999 Jul; 54(1):130-4. PubMed ID: 10414739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous blood transfusion: standard of care for the 1990s.
    Zond JR
    J Am Osteopath Assoc; 1992 May; 92(5):638-40, 643-5. PubMed ID: 1601699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional transfusion centre preoperative autologous blood donation programme: the first two years.
    Howard MR; Chapman CE; Dunstan JA; Mitchell C; Lloyd HL
    BMJ; 1992 Dec; 305(6867):1470-3. PubMed ID: 1493393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of an educational intervention to decrease inappropriate preoperative autologous blood donation: its effectiveness and the effect on subsequent transfusion rates in elective hysterectomy.
    Kanter MH; van Maanen D; Anders KH; Castro F; Win Mya W; Clark K
    Transfusion; 1999 Aug; 39(8):801-7. PubMed ID: 10504113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefits and risks of scheduled autologous transfusion].
    Danic B; Beauplet A
    Transfus Clin Biol; 1998 Oct; 5(5):313-25. PubMed ID: 9836392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating plasma holds in the presence of multiple infections.
    Kaplan EH
    IMA J Math Appl Med Biol; 2001 Sep; 18(3):215-24. PubMed ID: 11817743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on predeposit autologous blood donation and transfusion in Europe.
    Politis C; Richardson SC
    Vox Sang; 2004 Aug; 87(2):105-8. PubMed ID: 15355501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The issues in autologous transfusion.
    Simon TL; Smith KJ
    Hum Pathol; 1989 Jan; 20(1):3-6. PubMed ID: 2912872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current autologous transfusion practices. Implications for the future.
    Anderson BV; Tomasulo PA
    Transfusion; 1988; 28(4):394-6. PubMed ID: 3388487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed-donor programs may adversely affect autologous donor participation.
    Chambers LA; Kruskall MS; Drago SS; Ellis AM
    Transfusion; 1990; 30(3):246-8. PubMed ID: 2315997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative autologous blood donation and transfusion in gynecology].
    Foglia G; Corticelli A; Podestà M; Valenzano M; Rissone R; Giannini G; Valbonesi M
    Minerva Ginecol; 2000 Sep; 52(9):333-7. PubMed ID: 11189962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed blood procurement does not benefit patients who are enrolled in an autologous blood predeposit program.
    Goodnough LT
    Am J Clin Pathol; 1989 Oct; 92(4):484-7. PubMed ID: 2801612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997.
    Schmuñis GA; Zicker F; Segura EL; del Pozo AE
    Transfusion; 2000 Sep; 40(9):1048-53. PubMed ID: 10988304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.